Cited by 243Rheumatoid Arthritis Research and TherapiesT-cell and B-cell ImmunologyImmunotoxicology and immune responses

The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.

Chronic exposure to tumor necrosis factor (TNF) in vitro impairs the activation of T cells through the T cell receptor/CD3 complex; reversal in vivo by anti-TNF antibodies in patients with rheumatoid arthritis

Open access

Cope, A P, Londei, M, Chu, N R, Cohen, S B, Elliott, M J, Brennan, F M, Maini, R N, Feldmann, M·1994·Journal of Clinical Investigation

DOI 10.1172/jci117394PMC PMC296155

Open this paper in CoChat — free account Open PDF

Abstract

Experiments were designed to test the hypothesis that chronic exposure to tumor necrosis factor alpha (TNF) alters the function of activated T lymphocytes. Pretreatment of tetanus toxoid-specific T cell clones with TNF for up to 16 d impaired rechallenge proliferative responses to antigen in a dose- and time-dependent fashion. IL-2 and PHA responses were preserved. Prolonged treatment with TNF impaired production of IL-2, IL-10, IFN gamma, TNF, and lymphotoxin (LT) following stimulation with immobilized OKT3, and resulted in suboptimal expression of the IL-2R alpha chain (Tac) but not CD3, CD4, or HLA-DR antigens, when compared to untreated control cells. By contrast, pretreatment of T cells for prolonged periods in vitro with neutralizing anti-TNF monoclonal antibodies (mAb) enhanced proliferative responses, increased lymphokine production, and upregulated Tac expression following stimulation with OKT3. To determine whether TNF exerts immunosuppressive effects on T cells in vivo, we studied cell-mediated immunity in patients with active rheumatoid arthritis (RA), before and after treatment with a chimeric anti-TNF mAb. Treatment with anti-TNF restored the diminished proliferative responses of PBMC to mitogens and recall antigens towards normal in all patients tested. These data demonstrate that persistent expression of TNF in vitro and in vivo impairs cell-mediated immune responses.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1172/jci117394

Cites

60 of 60 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis
Arnett, F. C., Edworthy, S. M., Bloch, D. A., McShane, D. J., Fries, J. F., Cooper, N. S., Healey, L. A., Kaplan, S. R., Liang, M. H., Luthra, H. S., et al. (1988) · Arthritis & Rheumatism · doi:10.1002/art.1780310302 · Cited by 19,753
TH1 and TH2 Cells: Different Patterns of Lymphokine Secretion Lead to Different Functional Properties
Mosmann, T. R., & Coffman, R. L. (1989) · Annual Review of Immunology · doi:10.1146/annurev.iy.07.040189.001045 · Cited by 7,692
Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes.
de Waal Malefyt, R., Abrams, J., Bennett, B., Figdor, C. G., & de Vries, J. E. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.5.1209 · Cited by 3,762
Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production.
Ding, A. H., Nathan, C., & Stuehr, D. J. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.141.7.2407 · Cited by 2,840
The Biology Of Cachectin/TNF: A Primary Mediator Of The Host Response
Beutler, B., & Cerami, A. (1989) · Annual Review of Immunology · doi:10.1146/annurev.iy.07.040189.003205 · Cited by 1,690
Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis.
Keffer, J., Probert, L., Cazlaris, H. E., Georgopoulos, S., Kaslaris, E., Kioussis, D., & Kollias, G. A. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb04978.x · Cited by 1,670
Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1.
Dinarello, C. A., Cannon, J. G., Wolff, S. M., Bernheim, H. A., Beutler, B., Cerami, A., Figari, I. S., Palladino, M. A., & O'Connor, J. V. (1986) · The Journal of experimental medicine · doi:10.1084/jem.163.6.1433 · Cited by 1,472
Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon.
Pober, J. S., Gimbrone, M. A., Lapierre, L. A., Mendrick, D. L., Fiers, W., Rothlein, R., & Springer, T. A. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.137.6.1893 · Cited by 1,413
The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection
Kindler, V., Sappino, A., Grau, G. E., Piguet, P., & VASSALLI, P. (1989) · Cell · doi:10.1016/0092-8674(89)90676-4 · Cited by 1,239
Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts.
Dayer, J., Beutler, B., & Cerami, A. (1985) · The Journal of Experimental Medicine · doi:10.1084/jem.162.6.2163 · Cited by 1,208
INHIBITORY EFFECT OF TNF$alpha; ANTIBODIES ON SYNOVIAL CELL INTERLEUKIN-1 PRODUCTION IN RHEUMATOID ARTHRITIS
Brennan, F. M. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90430-3 · Cited by 1,141
Self-citation
A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: Ramifications for the complex physiology of TNF
Kriegler, M., Perez, C. F., DeFay, K., Albert, I., & Lu, S.-D. (1988) · Cell · doi:10.1016/0092-8674(88)90486-2 · Cited by 1,090
Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α
Elliott, M. J., Maini, R. N., Feldmann, M., Long-Fox, A., Charles, P. J., Katsikis, P. D., Brennan, F. M., Walker, J., Bijl, H., Ghrayeb, J., et al. (1993) · Arthritis & Rheumatism · doi:10.1002/art.1780361206 · Cited by 1,038
Self-citation
Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis.
Williams, R. O., Feldmann, M., & Maini, R. N. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.20.9784 · Cited by 991
Self-citation
Endothelial Cell Gene Expression of a Neutrophil Chemotactic Factor by TNF-α, LPS, and IL-1β
Strieter, R. M., Kunkel, S. L., Showell, H. J., Remick, D. G., Phan, S. H., Ward, P. A., & Marks, R. M. (1989) · Science · doi:10.1126/science.2648570 · Cited by 775
Potential antiinflammatory effects of interleukin 4: suppression of human monocyte tumor necrosis factor alpha, interleukin 1, and prostaglandin E2.
Hart, P. H., Vitti, G. F., Burgess, D. R., Whitty, G. A., Piccoli, D. S., & Hamilton, J. A. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.10.3803 · Cited by 742
Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation.
Tracey, K. J., He, W., Manogue, K. R., Fong, Y., HESSE, D. G., Nguyen, H. T., Kuo, G. C., Beutler, B., Cotran, R. S., & Cerami, A. (1988) · The Journal of Experimental Medicine · doi:10.1084/jem.167.3.1211 · Cited by 730
Tumors secreting human TNF/cachectin induce cachexia in mice
Oliff, A. I., Defeo-Jones, D., BOYER, M. E., Martinez, D., KIEFER, D. M., Vuocolo, G. A., Wolfe, A. L., & Socher, S. H. (1987) · Cell · doi:10.1016/0092-8674(87)90028-6 · Cited by 640
Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs.-host disease.
Piguet, P. F., Grau, G. E., Allet, B., & VASSALLI, P. (1987) · The Journal of Experimental Medicine · doi:10.1084/jem.166.5.1280 · Cited by 584
Recombinant human TNF induces production of granulocyte–monocyte colony-stimulating factor
Munker, R., Gasson, J. C., Ogawa, M., & Koeffler, H. P. (1986) · Nature · doi:10.1038/323079a0 · Cited by 500
Immunoregulatory activity of recombinant human tumor necrosis factor (TNF)-alpha: induction of TNF receptors on human T cells and TNF-alpha-mediated enhancement of T cell responses.
Scheurich, P., Thoma, B., Üçer, U., & Pfizenmaier, K. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.138.6.1786 · Cited by 492
Serum concentrations of tumour necrosis factor alpha in childhood chronic inflammatory bowel disease.
MURCH, S. H., Lamkin, V. A., Savage, M. O., Walker‐Smith, J. A., & MacDonald, T. T. (1991) · Gut · doi:10.1136/gut.32.8.913 · Cited by 482
Predominantly T-Cell Infiltrate in Rheumatoid Synovial Membranes
van Boxel, J. A., & Paget, S. A. (1975) · New England Journal of Medicine · doi:10.1056/nejm197509112931101 · Cited by 381
Tumor necrosis factor type alpha stimulates human endothelial cells to produce granulocyte/macrophage colony-stimulating factor.
Broudy, V. C., Kaushansky, K., Segal, G. M., Harlan, J. M., & Adamson, J. W. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.19.7467 · Cited by 373
Interleukin-1 and tumour necrosis factor mRNA expression in rheumatoid arthritis: prolonged production of IL-1 alpha.
Buchan, G. S., Barrett, K., Turner, M., Chantry, D., Maini, R. N., & Feldmann, M. (1988) · PubMed Central · Cited by 332
Self-citation
Modulation of cytokine production by transforming growth factor-beta.
Chantry, D., Turner, M., Abney, E. R., & Feldmann, M. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.142.12.4295 · Cited by 323
Self-citation
Human T-Cell Clones from Autoimmune Thyroid Glands: Specific Recognition of Autologous Thyroid Cells
Londei, M., Bottazzo, G. F., & Feldmann, M. (1985) · Science · doi:10.1126/science.3871967 · Cited by 313
Self-citation
Expression of granulocyte‐macrophage colony‐stimulating factor in rheumatoid arthritis: Regulation by tumor necrosis factor‐α
Haworth, C., Brennan, F. M., Chantry, D., Turner, M., Maini, R. N., & Feldmann, M. (1991) · European Journal of Immunology · doi:10.1002/eji.1830211039 · Cited by 299
Self-citation
Tumor necrosis factor is involved in the T cell-independent pathway of macrophage activation in scid mice.
Bancroft, G. J., Sheehan, K. C. F., Schreiber, R. D., & Unanue, E. R. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.143.1.127 · Cited by 270
Phenotypic analysis of synovial tissue and peripheral blood lymphocytes isolated from patients with rheumatoid arthritis
Cush, J. J., & Lipsky, P. E. (1988) · Arthritis & Rheumatism · doi:10.1002/art.1780311003 · Cited by 247
Cytokines in chronic inflammatory arthritis. I. Failure to detect T cell lymphokines (interleukin 2 and interleukin 3) and presence of macrophage colony-stimulating factor (CSF-1) and a novel mast cell growth factor in rheumatoid synovitis.
Firestein, G. S., Xu, W. D., Townsend, K., Broide, D. H., Alvaro-Gracia, J., Glasebrook, A. L., & Zvaifler, N. J. (1988) · The Journal of Experimental Medicine · doi:10.1084/jem.168.5.1573 · Cited by 247
Tumor necrosis factor enhances HLA-A,B,C and HLA-DR gene expression in human tumor cells.
Pfizenmaier, K., Scheurich, P., Schlüter, C., & Krönke, M. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.138.3.975 · Cited by 245
Effect of tumor necrosis factor alpha on mitogen-activated human B cells.
Kehrl, J. H., MILLER, A. R., & Fauci, A. S. (1987) · The Journal of Experimental Medicine · doi:10.1084/jem.166.3.786 · Cited by 234
Enhancement of antigen- and mitogen-induced human T lymphocyte proliferation by tumor necrosis factor- alpha .
Yokota, S., Geppert, T. D., & Lipsky, P. E. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.140.2.531 · Cited by 219
Peripheral blood and synovial fluid monocyte activation in inflammatory arthritis. ii. low levels of synovial fluid and synovial tissue interferon suggest that γgm‐interferon is not the primary macrophage activating factor
Firestein, G. S., & Zvaifler, N. J. (1987) · Arthritis & Rheumatism · doi:10.1002/art.1780300804 · Cited by 176
Cytokine production in the rheumatoid joint: implications for treatment.
Feldmann, M., Brennan, F. M., Chantry, D., Haworth, C., Turner, M., Abney, E. R., Buchan, G. S., Barrett, K., Barkley, D., & Chu, A. C. (1990) · PubMed · Cited by 146
Self-citation
THE ASSESSMENT OF DISEASE ACTIVITY IN RHEUMATOID ARTHRITIS USING A MULTIVARIATE ANALYSIS
Mallya, R. K., & MACE, B. E. W. (1981) · Lara D. Veeken · doi:10.1093/rheumatology/20.1.14 · Cited by 136
A novel addition to the T cell repertory. Cell surface expression of tumor necrosis factor/cachectin by activated normal human T cells.
Kinkhabwala, M. M., Sehajpal, P. K., Skolnik, E. Y., Smith, D. R., Sharma, V. K., Vlassara, H., Cerami, A., & Suthanthiran, M. (1990) · The Journal of Experimental Medicine · doi:10.1084/jem.171.3.941 · Cited by 132
Immunomodulatory properties of recombinant murine and human tumor necrosis factor.
Talmadge, J. E., Phillips, H., Schneider, M., Rowe, T., Pennington, R. M., Bowersox, O., & Lenz, B. F. (1988) · PubMed · Cited by 129
Circulating interleukin 6 during a continuous infusion of tumor necrosis factor and interferon gamma.
Brouckaert, P., Spriggs, D. R., Demetri, G. D., Kufe, D. W., & Fiers, W. (1989) · The Journal of Experimental Medicine · doi:10.1084/jem.169.6.2257 · Cited by 120
Expression of tumor necrosis factor receptors on human monocytes and internalization of receptor bound ligand.
Imamura, K., Spriggs, D. R., & Kufe, D. W. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.139.9.2989 · Cited by 103
Altered lymphocyte reactivity in rheumatoid arthritis
Silverman, H. A., Johnson, J. S., Vaughan, J. H., & McGlamory, J. C. (1976) · Arthritis & Rheumatism · doi:10.1002/art.1780190301 · Cited by 95
Human T cells from autoimmune and normal individuals can produce tumor necrosis factor
Turner, M., Londei, M., & Feldmann, M. (1987) · European Journal of Immunology · doi:10.1002/eji.1830171220 · Cited by 92
Self-citation
Enhanced expression of tumor necrosis factor receptor mRNA and protein in mononuclear cells isolated from rheumatoid arthritis synovial joints
Brennan, F. M., Gibbons, D. L., Cope, A. P., Feldmann, M., Mitchell, T. J., & Maini, R. N. (1992) · European Journal of Immunology · doi:10.1002/eji.1830220734 · Cited by 91
Self-citation
Interleukin-2 reverses deficient cell-mediated immune responses in rheumatoid arthritis.
Emery, P., Panayi, G. S., & Nouri, A. M. E. (1984) · PubMed Central · Cited by 87
Regulation of expression of human IL-1 alpha and IL-1 beta genes.
Turner, M., Chantry, D., Buchan, G. S., Barrett, K., & Feldmann, M. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.143.11.3556 · Cited by 87
Self-citation
Effects of recombinant murine tumor necrosis factor- alpha on immune function.
Gordon, C., & Wofsy, D. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.5.1753 · Cited by 85
Tumor necrosis factor in serum and cerebrospinal fluid of patients with multiple sclerosis
Franciotta, D. M., Grimaldi, L. M. E., Martino, G., Piccolo, G., Bergamaschi, R., Citterio, A., & d’Eril, G. V. M. (1989) · Annals of Neurology · doi:10.1002/ana.410260618 · Cited by 83
Abnormalities in CD4+ T-lymphocyte subsets in inflammatory rheumatic diseases
Morimoto, C., Romain, P. L., Fox, D. A., Anderson, P., Dimaggio, M., Levine, H., & Schlossman, S. F. (1988) · The American Journal of Medicine · doi:10.1016/0002-9343(88)90058-7 · Cited by 83
Serum Tumor Necrosis Factor Levels and Disease Dissemination in Leprosy and Leishmaniasis
Pisa, P., Mengistu, G., Söder, O., Ottenhoff, T. H. M., Hansson, M., & Kiessling, R. W. (1990) · The Journal of Infectious Diseases · doi:10.1093/infdis/161.5.988 · Cited by 72
II. EVIDENCE THAT ANTIBODY THERAPY AGAINST TUMOR NECROSIS FACTOR-ALPHA AND LYMPHOTOXIN ENHANCES CARDIAC ALLOGRAFT SURVIVAL IN RATS
Imagawa, D. K., Millis, J. M., Olthoff, K. M., Seu, P., Dempsey, R. A., HART, J., Terasaki, P. I., Wasef, E., & Busuttil, R. W. (1990) · Transplantation · doi:10.1097/00007890-199008000-00003 · Cited by 62
Anti-tumor necrosis factor antibodies suppress cell-mediated immunity in vivo
Bromberg, J. S., Chavin, K. D., & Kunkel, S. L. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.11.3412 · Cited by 61
Studies of rheumatoid synovial fluid lymphocytes
Silver, R. M., Redelman, D. D., & Zvaifler, N. J. (1983) · Clinical Immunology and Immunopathology · doi:10.1016/0090-1229(83)90052-1 · Cited by 57
The effects ofPlasmodium falciparummalaria on immune control of B lymphocytes in Gambian children
Whittle, H., Brown, J. L., Marsh, K., Blackman, M. J., Jobe, O., & Shenton, F. C. (1990) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1990.tb05236.x · Cited by 53
Immune function in severe, active rheumatoid arthritis: a relationship between peripheral blood mononuclear cell proliferation to soluble antigens and mononuclear cell subset profiles.
Haraoui, B. P., Wilder, R. L., Malone, D. G., Allen, J. B., Katona, I. M., & Wahl, S. M. (1984) · The Journal of Immunology · doi:10.4049/jimmunol.133.2.697 · Cited by 50
Differential bioassay of interleukin 2 and interleukin 4
Ho, S. N., Abraham, R. T., Gillis, S. A., & McKEAN, D. J. (1987) · Journal of Immunological Methods · doi:10.1016/0022-1759(87)90441-8 · Cited by 42
Differential regulation of tumour necrosis factor receptors (TNF-R) by IL-4; upregulation of P55 and P75 TNF-R on synovial joint mononuclear cells
Cope, A. P., Gibbons, D. L., Aderka, D., Foxwell, B. M. J., Wallach, D., Maini, R. N., Feldmann, M., & Brennan, F. M. (1993) · Cytokine · doi:10.1016/1043-4666(93)90006-q · Cited by 37
Self-citation
Human tumour necrosis factors-α and -β: Differences in their structure, expression and biological properties
Porter, A. G. (1990) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1990.tb03519.x · Cited by 18
Differences in the biological activity of TNF alpha and TNF beta correlate with their different abilities for binding to the target cells.
Kircheis, R., Milleck, J., Коробко, В. Г., Shingarova, L. N., & Schmidt, H. E. (1992) · PubMed · Cited by 16
Cytokine Production in Culture by Cells Isolated from the Synovial Membrane
Brennan, F. M., Chantry, D., Jackson, A. M., Mainif, R. N., & Feldmann, M. (1989) · Elsevier eBooks · doi:10.1016/b978-0-12-252682-4.50022-6 · Cited by 14
Self-citation

Research works printed but not linked: 1

Hart, P. H., G. F. Vitti, D. R. Burgess, G. A. Whitty, D. S. Piccoli, and J. H. Hamilton. 1989. Potential anti-inflammatory effects of interleukin-4: Suppression of human monocyte tumor necorsis factor a, interleukin-1, and pros- taglandin E2. Proc. Natl. Acad. Sci. USA. 86:3803-3807.

Sorted by citations

A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor α for Crohn's Disease
Targan, S. R., Hanauer, S. B., van Deventer, S. J. H., Mayer, L., Present, D. H., Braakman, T., DeWoody, K. L., Schaible, T. F., & Rutgeerts, P. J. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710093371502 · Cited by 3,135
ROLE OF CYTOKINES IN RHEUMATOID ARTHRITIS
Feldmann, M., Brennan, F. M., & Maini, R. N. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.397 · Cited by 2,507
Self-citation
Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritis
Elliott, M. J., Maini, R. N., Feldmann, M., Kalden, J. R., Antoni, C., Smolen, J. S., Leeb, B., Breedveld, F. C., Macfarlane, J. D., Bijl, J. A., et al. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90628-9 · Cited by 1,682
Self-citation
Tumor necrosis factor antagonist mechanisms of action: A comprehensive review
Tracey, D. E., Klareskog, L., Sasso, E. H., Salfeld, J. G., & Tak, P. P. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.10.001 · Cited by 1,658
TFOS DEWS II Management and Therapy Report
Jones, L., Downie, L. E., Korb, D. R., Benitez-del-Castillo, J., Dana, R., Deng, S. X., Dong, P. N., Geerling, G., Hida, R. Y., Liu, Y., et al. (2017) · The Ocular Surface · doi:10.1016/j.jtos.2017.05.006 · Cited by 1,506

See all 243

Authors: Cope, A. P., Londei, M., Chu, N. R., Cohen, S. B., Elliott, M. J., Brennan, F. M., Maini, R. N., & Feldmann, M.
Affiliations: Kennedy Institute of Rheumatology (GB)
ORCID: Cope, A P
Feldmann, M
Venue: Journal of Clinical Investigation
Publisher: American Society for Clinical Investigation
Published: 1994-08-01
Volume: 94
Issue: 2
Pages: 749-760
ISSN: 0021-9738 (ISSN-L)
DOI: 10.1172/jci117394
PMC: PMC296155
OpenAlex: W1985680749
Cited by: 243
References: 60
Citations by year: 2026: 1 · 2024: 2 · 2023: 1 · 2022: 2 · 2021: 1 · 2019: 9 · 2018: 4 · 2017: 3 · 2016: 5 · 2015: 5 · 2014: 7 · 2013: 7 · 2012: 10
FWCI: 9.33
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Journal of Clinical Investigation (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: Wellcome Trust
Medical Research Council
Topics: Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
Life Sciences › Immunology and Microbiology › Immunology › Immunotoxicology and immune responses
Keywords: TNF-α, T cell activation, T cell receptor/CD3 complex, anti-TNF monoclonal antibody, rheumatoid arthritis, cell-mediated immunity, immunosuppression, IL-2 receptor alpha chain, OKT3, lymphokine production, T cell clones
MeSH terms: Antibodies, Monoclonal, Antigen-Presenting Cells, Arthritis, Rheumatoid, Cells, Cultured, Dose-Response Relationship, Drug, HLA-DR Antigens, Humans, Interleukin-2, Lymphocyte Activation, Lymphokines, T-Lymphocytes, Tumor Necrosis Factor-alpha, CD4 Antigens, Receptor-CD3 Complex, Antigen, T-Cell

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Chronic exposure to tumor necrosis factor (TNF) in vitro impairs the activation of T cells through the T cell receptor/CD3 complex; reversal in vivo by anti-TNF antibodies in patients with rheumatoid arthritis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks